|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
10,650,000 |
Market
Cap: |
1.25(M) |
Last
Volume: |
1,291,850 |
Avg
Vol: |
1,288,278 |
52
Week Range: |
$0.1174 - $0.1174 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Rosenman Herm |
Director |
|
2018-06-01 |
4 |
B |
$0.77 |
$38,500 |
I/I |
50,000 |
50,000 |
2.1 |
- |
|
Rosenman Herm |
Director |
|
2018-05-29 |
4 |
B |
$0.79 |
$39,500 |
D/D |
50,000 |
286,671 |
2.39 |
- |
|
Rosenman Herm |
Director |
|
2018-05-21 |
4 |
B |
$0.81 |
$81,000 |
D/D |
100,000 |
236,671 |
2.39 |
- |
|
Rosenman Herm |
Director |
|
2018-05-21 |
4 |
OE |
$0.70 |
$52,500 |
D/D |
75,000 |
136,671 |
|
- |
|
Amos John P. |
Chief Executive Officer |
|
2018-05-18 |
4 |
S |
$0.77 |
$1,156 |
D/D |
(1,500) |
1,708,500 |
|
- |
|
Amos John P. |
Chief Executive Officer |
|
2018-05-18 |
4 |
B |
$0.77 |
$208,089 |
D/D |
270,000 |
1,710,000 |
2.81 |
- |
|
Amos John P. |
Chief Executive Officer |
|
2018-05-17 |
4 |
B |
$0.69 |
$249,228 |
D/D |
360,000 |
1,440,000 |
2.81 |
- |
|
Amos John P. |
Chief Executive Officer |
|
2018-05-16 |
4 |
B |
$0.58 |
$156,546 |
D/D |
270,000 |
1,080,000 |
2.81 |
- |
|
Shaw Allan |
Consultant |
|
2018-05-15 |
4 |
D |
$0.52 |
$228 |
D/D |
(438) |
60,076 |
|
- |
|
Shaw Allan |
Consultant |
|
2018-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,389 |
60,514 |
|
- |
|
Amos John P. |
Chief Executive Officer |
|
2018-05-15 |
4 |
B |
$0.54 |
$146,529 |
D/D |
270,000 |
810,000 |
2.81 |
- |
|
Roberts Eric W |
Director |
|
2018-05-15 |
4 |
D |
$0.52 |
$258 |
D/D |
(497) |
77,780 |
|
- |
|
Roberts Eric W |
Director |
|
2018-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,389 |
78,277 |
|
- |
|
Amos John P. |
Chief Executive Officer |
|
2018-05-14 |
4 |
B |
$0.51 |
$138,672 |
D/D |
270,000 |
540,000 |
2.81 |
- |
|
Amos John P. |
Chief Executive Officer |
|
2018-05-11 |
4 |
B |
$0.52 |
$139,914 |
D/D |
270,000 |
270,000 |
2.81 |
- |
|
Shaw Allan |
Consultant |
|
2018-04-15 |
4 |
D |
$0.42 |
$184 |
D/D |
(438) |
59,125 |
|
- |
|
Shaw Allan |
Consultant |
|
2018-04-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,389 |
59,563 |
|
- |
|
Roberts Eric W |
Director |
|
2018-04-15 |
4 |
D |
$0.42 |
$184 |
D/D |
(438) |
76,888 |
|
- |
|
Roberts Eric W |
Director |
|
2018-04-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,389 |
77,326 |
|
- |
|
Varghese Santosh T |
Chief Medical Officer |
|
2018-04-03 |
4 |
S |
$0.34 |
$132 |
D/D |
(390) |
71,415 |
|
- |
|
Slebir John L |
SVP, Business Development & GC |
|
2018-04-01 |
4 |
D |
$0.36 |
$199 |
D/D |
(559) |
134,010 |
|
- |
|
Roberts Eric W |
Director |
|
2018-03-15 |
4 |
D |
$0.48 |
$210 |
D/D |
(438) |
75,937 |
|
- |
|
Roberts Eric W |
Director |
|
2018-03-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,389 |
76,375 |
|
- |
|
Shaw Allan |
Consultant |
|
2018-03-15 |
4 |
D |
$0.48 |
$210 |
D/D |
(438) |
58,174 |
|
- |
|
Shaw Allan |
Consultant |
|
2018-03-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,389 |
58,612 |
|
- |
|
555 Records found
|
|
Page 2 of 23 |
|
|